{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:53:35Z","timestamp":1781733215503,"version":"3.54.5"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Botulinum neurotoxin (BoNT) is approved as single-use vials containing doses higher than necessary for most patients, which contributes to waste and lost revenue. It is common practice to administer a single-use BoNT vial to multiple patients, but data are lacking to support the safety of this practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To determine the safety and efficacy of a multiuse vial protocol for BoNT at an academic medical center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>A retrospective review of the electronic medical record identified patients receiving cosmetic BoNT at Oregon Health &amp; Science University between 2020 and 2025. Adverse events that occurred within 30 days of the procedure were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 2,666 patients receiving cosmetic BoNT were included. Overall, 354 (13.28%) follow-ups occurred within 30 days, and 39 (1.46%) adverse events occurred. The majority of these were related to inadequate paralysis (16) or asymmetrical paralysis (12). No serious complications or infections were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Complications when using a multiuse vial policy for BoNT are infrequent and not related to infection. Adoption of similar policies nationwide will lead to a reduction in medical waste and increased revenue.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000004960","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:00:48Z","timestamp":1780045248000},"page":"583-585","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Efficacy of a Multi-use Neurotoxin Protocol in Academic Settings"],"prefix":"10.1097","volume":"52","author":[{"given":"Michael","family":"Shaughnessy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Kean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Leitenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bar","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Department of Dermatology, Oregon Health & Science University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"R1-20260617","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jocd.15513","article-title":"Botulinum toxin for cosmetic treatments in young adults: an evidence-based review and survey on current practice among aesthetic practitioners","volume":"22","author":"Michon","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"R3-20260617","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/DSS.0000000000004567","article-title":"The history of neuromodulators in dermatologic surgery","volume":"51","author":"Cespedes Zablah","year":"2025","journal-title":"Dermatol Surg"},{"key":"R6-20260617","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/ajhp\/61.suppl_6.S24","article-title":"Proper dose, preparation, and storage of botulinum neurotoxin serotype A","volume":"61","author":"Anderson","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"R7-20260617","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jaad.2011.10.008","article-title":"Recommendations and current practices for the reconstitution and storage of botulinum toxin type A","volume":"67","author":"Liu","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R8-20260617","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/01.PRS.0000144795.76040.D3","article-title":"Consensus recommendations on the use of botulinum toxin type A in facial aesthetics","volume":"114","author":"Carruthers","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"R9-20260617","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/DSS.0000000000000303","article-title":"Consensus statement regarding storage and reuse of previously reconstituted neuromodulators","volume":"41","author":"Alam","year":"2015","journal-title":"Dermatol Surg"},{"key":"R10-20260617","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archfaci.10.4.273","article-title":"Questioning the need to use Botox within 4 hours of reconstitution: a study of fresh vs 2-week-old Botox","volume":"10","author":"Yang","year":"2008","journal-title":"Arch Facial Plast Surg"},{"key":"R11-20260617","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1524-4725.1998.tb04094.x","article-title":"Dilution and storage of botulinum toxin","volume":"24","author":"Klein","year":"1998","journal-title":"Dermatol Surg"},{"key":"R13-20260617","doi-asserted-by":"crossref","first-page":"i788","DOI":"10.1136\/bmj.i788","article-title":"Overspending driven by oversized single dose vials of cancer drugs","volume":"352","author":"Bach","year":"2016","journal-title":"BMJ"},{"key":"R15-20260617","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jvoice.2017.11.004","article-title":"Multidose botulinum toxin A for intralaryngeal injection: a cost analysis","volume":"33","author":"Gilbert","year":"2019","journal-title":"J Voice"},{"key":"R16-20260617","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaad.2006.01.019","article-title":"Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation","volume":"55","author":"Alam","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R17-20260617","first-page":"523","article-title":"Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application","volume":"29","author":"Hexsel","year":"2003","journal-title":"Dermatol Surg"},{"key":"R18-20260617","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00266-006-0161-1","article-title":"Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use","volume":"31","author":"Parsa","year":"2007","journal-title":"Aesthet Plast Surg"},{"key":"R19-20260617","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","article-title":"Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases","volume":"53","author":"Cot\u00e9","year":"2005","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:02:16Z","timestamp":1781730136000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004960","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}